Position in ELAN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$30,551,690
+$800,598 QoQ
Shares Held
1,241,434
-0.1% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#59
of 518 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $48,081,797 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (63.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
This page
|
1,241,434 | $30,551,690 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
19,047 | $10,320,236 | |
| 3 | ZTS |
Zoetis Inc.
|
59,650 | $4,286,449 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
57,395 | $1,944,542 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
5,808 | $978,880 |
All Filings in ELAN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,551,690 | 1,241,434 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $29,751,092 | 1,243,255 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $30,038,450 | 1,327,373 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $32,429,287 | 1,610,193 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $28,042,835 | 1,963,784 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $23,743,765 | 2,261,311 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||